Welcome to Amayeza Information Centre

We are an independant medicine information centre that aims to provide reliable, accurate, objective, and up-to-date information on medicine to pharmacists and other health care professionals across South Africa.

Please note that our services are subscription-based. In order for you to benefit from our up-to-date medicine information, you will need to be a subscriber of Amayeza Information Services. For more information regarding subscriptions, click here


The word “Amayeza” means “Medicine” in the Xhosa language.



As part of the global Polio Eradication Initiative, the polio endgame strategic plan (2013-2018) was formulated in 2012. One of the key objectives is to remove OPV and thereby eliminate the risk of Vaccine Associated Paralytic Polio (VAPP). This however has to be done in stages.

All trivalent OPV (t-OPV) will be replaced with bivalent OPV (b-OPV) and this switch must be synchronised worldwide to minimise the risk of Vaccine-derived polio virus infection with type 2.

The switch date in South Africa is April 20th and we are fast approaching this date! If you stock any OPV and have not been contacted by the Department of Health in your area, please contact the coordinator in your area as soon as possible so that arrangements can be made to collect your t-OPC stock and replace it with b-OPV.

For further details, Click here. If you are unable to contact anyone, send an email to lee@amayeza-info.co.za.  For a list of coordinators, click here.



ZIKA VIRUS: Public Health Emergency

The World Health Organization designated the Zika virus and its suspected complications in newborns as a public health emergency of international concern.

Zika virus is spread to people through mosquito bites. The most common symptoms of Zika virus disease are fever, rash, joint pain, and conjunctivitis (red eyes). The illness is usually mild with symptoms lasting from several days to a week. Severe disease requiring hospitalization is uncommon.

In May 2015, the Pan American Health Organization (PAHO) issued an alert regarding the first confirmed Zika virus infection in Brazil. The outbreak in Brazil led to reports of Guillain-Barré syndrome and pregnant women giving birth to babies with birth defects and poor pregnancy outcomes.

Sources: CNN; Centre for Disease Control and Prevention (CDC); World Health Organization



Immunisation schedule 2016


Typhoid Fever in Johannesburg

The Gauteng Health Department on Sunday confirmed that four cases of typhoid fever have been identified within Johannesburg – Hillbrow, Yeoville, Edenvale, and Palm Springs.

Four cases of typhoid including one death, were confirmed in Johannesburg over the past week. This prompted a rapid investigation by the Gauteng department of Health. Three of the cases were imported related to travel in southern Africa. Other than the two cases from the same family there were no links between the cases.

The investigation has shown that there is no current outbreak of typhoid in Johannesburg. Additional laboratory studies will follow. Typhoid is endemic in Africa including South Africa. Fever, headache and abdominal pain are common symptoms. Antibiotic therapy is effective in the majority of cases.

Sources: South African Society of Travel Medicine (SASTM); National Institute of Communicable Diseases (NICD)





Useful links:

Immunisation schedules 2016


Ebola Virus Disease PDF Download

Disease Notification System

Amayeza subscription form

South African Society of Travel Medicine (SASTM) Publications:

Beyond Childhood Vaccination: http://www.sastm.org.za/sastm_publication.php?id=34

A Guide to the Practice of Travel Medicine




Data Privacy Statement

Amayeza Information Services stores any personal information to enable us to address the enquiry, or other such matters that have been raised, and to document our response. The information will be retained in a secure server and will only be used for this purpose, unless required for legal proceedings. If reporting an adverse event, the information provided will be used in order to meet regulatory requirements in relation to the safety of medicines. In accordance with applicable law, you may have a right to access and correct your information. If you would prefer that Amayeza does not store your personal data, please let us know.



Last updated: 26 April 2016

Comments are closed.